Weidong Lu received his Bachelor of Medicine from Zhejiang College of Traditional Chinese Medicine in Hangzhou, China in 1983 and Master of Public Health from Harvard School of Public Health in 2002. He is professor of Chinese Medicine and the past chairman of Chinese Herbal Medicine Department at The New England School of Acupuncture. He has been on staff as a licensed acupuncturist at Zakim Center for Integrative Therapies at Dana-Farber Cancer Institute since 2000.
Lu is the co-leader of NIH-funded acupuncture trial for chemotherapy induced neutropenia and the first recipient of The Bernard Osher Foundation/NCCAM CAM Practitioner Research Career Development Award. Currently, he is conducting an acupuncture trial on dysphagia in head and neck cancer. He has a faculty appointment at Osher Research Center, Harvard Medical School. His primary research interests are in conducting clinical trials of acupuncture for cancer related symptoms; Chinese herbal medicine in practice, TCM pattern diagnoses and related underling mechanisms.